It functions as an organoprotective agent, attributing its beneficial effects to its own activity rather than acting as a prophylactic agent
Aqua/Water/Eau, Peg-8, Cellulose, Butylene Glycol, Glycerin, Peg-7 Glyceryl Cocoate, Hamamelis Virginiana (Witch Hazel) Water, Phenoxyethanol, Carbomer, Saccharide Isomerate, Benzophenone-3, Panthenol, Alcohol, Chlorphenesin, Sodium Hydroxide, Fragrance, Disodium EDTA, Ananas Sativus (Pineapple) Fruit Extract, Propylene Glycol, Citric Acid, Guar Hydroxypropyltrimonium Chloride, Sodium Citrate, Panthenyl Triacetate, Taraxacum Officinale (Dandelion) Rhizome/Root Extract, Pantolactone, Hydroxyethylcellulose, Hydroxypropylcellulose, Centaurea Cyanus Flower Extract, BHT, Ethylhexylglycerin, Titanium Dioxide (CI 77891), Fd&C Blue No
Impact of Glyoxalase-I (Glo-I) and Advanced Glycation End Products (AGEs) in Chronic Liver Disease in Liver Cirrhosis - Update and Current Challenges, InTech
Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
Most promisingly, we could successfully soak in and solve crystal structures with the NMR hit 27 and several of its analogues to fully characterise the binding modes within this fragment hit series
BPC-157 exists in a regulatory grey area across most jurisdictions, including the UAE
